4//SEC Filing
Puttagunta Sailaja 4
Accession 0001209191-21-069494
CIK 0001659323other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:00 PM ET
Size
8.5 KB
Accession
0001209191-21-069494
Insider Transaction Report
Form 4
Puttagunta Sailaja
Chief Medical Officer
Transactions
- Award
Share Option (Right to Buy)
2021-12-10+1,800,000→ 1,800,000 totalExercise: $0.48Exp: 2031-12-09→ Ordinary Shares (1,800,000 underlying) - Award
Restricted Share Units
2021-12-10+500,000→ 500,000 total→ Ordinary Shares (500,000 underlying)
Footnotes (3)
- [F1]The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of December 1, 2021 and the remaining 75% will vest in equal monthly installments thereafter until December 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.
- [F2]Each restricted share unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.
- [F3]Subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date and the other terms and conditions of the Issuer's 2021 Inducement Equity Incentive Plan, the RSUs shall vest over four years with 25% of the RSUs vesting on each one-year anniversary of December 1, 2021, such that the total number of RSUs shall be fully vested by December 1, 2025.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001792314
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 5:00 PM ET
- Size
- 8.5 KB